Idiopathic interstitial pneumonias are a diverse group of lung diseases with varied prognoses. We hypothesized that changes in physiologic and radiographic parameters would predict survival. We retrospectively examined 80 patients with usual interstitial pneumonia and 29 patients with nonspecific interstitial pneumonia. Baseline characteristics were examined together with 6-month change in forced vital capacity, diffusing capacity for carbon monoxide, and ground glass infiltrate and fibrosis on high resolution computed tomography. Patients with usual interstitial pneumonia were more likely to have a statistically significant or marginally significant decline in lung volume, diffusing capacity for carbon monoxide, and an increase in ground glass infiltrates (p р 0.08) compared with patients with nonspecific interstitial pneumonia. For patients with usual interstitial pneumonia, change in forced vital capacity was the best physiologic predictor of mortality (p ϭ 0.05). In a multivariate Cox proportional hazards model controlling for histopathologic diagnosis, gender, smoking history, baseline forced vital capacity, and 6-month change in forced vital capacity, a decrease in forced vital capacity remained an independent risk factor for mortality (decrease Ͼ 10%; hazard ratio 2.47; 95% confidence interval 1.29, 4.73; p ϭ 0.006). We conclude that a 6-month change in forced vital capacity gives additional prognostic information to baseline features for patients with idiopathic interstitial pneumonia.
Idiopathic interstitial pneumonias are a group a diffuse parenchymal diseases. Usual interstitial pneumonia (UIP) and nonspecific interstitial pneumonia (NSIP) comprise the majority of idiopathic interstitial pneumonia cases; UIP is associated with the worst prognosis (1) (2) (3) (4) (5) .
Recent efforts to predict prognosis for individuals with idiopathic interstitial pneumonia have centered on baseline physiologic (1, 6, 7) , radiographic (7) (8) (9) , and pathologic testing (1) (2) (3) (4) (5) (6) 10) . Little information has been published regarding the association of serial changes in pulmonary function (11) or radiographic features (12) and prognosis. We hypothesized that short-term serial changes in pulmonary function and high-resolution computed tomography (HRCT) would predict long-term survival in patients with histologically defined UIP and NSIP.
METHODS

Patient Selection
Patients with a surgical lung biopsy and serial physiologic and/or HRCT data referred by participants in the University of Michigan Fibrotic Lung Disease Network between October, 1989, and February, 2000, were eligible for the current study. Patients were referred due to a suspicion of idiopathic interstitial pneumonia. Two pathologists (T.V.C., W.D.T.), blinded to the clinical features, assigned a histologic diagnosis using defined criteria (1, 13, 14) . Only patients with UIP and NSIP formed the study group. These patients represent a subset of previously reported patients (1) . The study was approved by the Institutional Review Board at the University of Michigan.
Physiologic Testing and HRCT
Pulmonary function tests (PFT), including spirometry, lung volumes, and diffusion capacity for carbon monoxide (Dl CO) , were performed as previously described (9) . HRCT examinations were performed with 1.0-or 1.5-mm-thick sections and scored on a scale of 0-5 for ground glass opacity (CT-alv) and interstitial opacity (CT-fib) as previously described (15) .
Therapy
Patients were treated with varied treatment regimens ( Table 1) . The lack of a standardized, prospective treatment regimen in the majority of patients limited our ability to evaluate if a clear treatment effect on survival or serial change in PFT and HRCT was present.
Statistical Analysis
Changes in PFT and HRCT scores were determined by estimating percent change for absolute value of HRCT and PFT measurements over a 6-month period. Measurements over a 6-month period related to the biopsy time were used to fit a linear regression for each patient. The fitted line from the linear regression was then used to estimate a 6-month measurement, which, together with the baseline measurement, allowed the calculation of percent change. Percent change values over 12 months were similarly created for patients with additional data over a 12-month period.
The date of surgical lung biopsy was used to mark the beginning of the survival time period for each individual. Death and follow-up times were supplemented by the use of the Social Security Death Master File (16) . Patients who had not been seen within 3 months and who did not appear in the Social Security Death Master File were called to confirm their vitality. Event times 3 months before the date of analysis were censored. Three patients underwent a lung transplant; physiologic, radiographic, and survival information was censored at the time of transplant. Cox proportional hazards models were used to examine the influence on survival of percent change for HRCT and PFT measurements while adjusting for histopathologic diagnosis, onset of symptoms, gender, and smoking status. The levels of more than 10% increase, between 10% decrease and 10% increase, and more than 10% decrease were used to study percent changes of the PFT and HRCT scores. These cutoff points were chosen a priori as they were believed to be clinically reasonable. Survival proportions were estimated and displayed using Cox proportional hazards models evaluated for average covariate profiles in the study population. Characteristics for UIP versus NSIP were compared using t tests for continuous measures and chi-square statistics and Fisher's Definition of abbreviations: NSIP ϭ nonspecific interstitial pneumonia; UIP ϭ usual interstitial pneumonia.
* Thirty-one of these patients received prednisone as part of a prospective study of high-dose steroids in idiopathic pulmonary fibrosis.
† A subset of patients were treated in a phase I/II trial comparing zileuton with azathioprine at our institution. exact (17) statistics for categoric measures. The potential interaction of variables that were significantly different at baseline (UIP compared with NSIP) and histologic diagnosis were also evaluated in multivariate survival models. Significance of individual risk factors were tested using Wald tests, whereas grouped risk factors were tested using likelihood ratio tests. The proportionality assumptions were tested using Schoenfeld residuals.
RESULTS
Baseline Characteristics
One hundred and nine patients with UIP (n ϭ 80) and NSIP (n ϭ 29) were identified. Patients with UIP were older, had a longer duration of symptoms, had a lower percent-predicted total lung capacity (TLC), and more fibrosis on HRCT (Table  2) . Gender distribution, CT-alv scores, and other measures of pulmonary physiology were similar between groups. 
Definition of abbreviations:
CT-alv ϭ high-resolution computed tomography score for ground glass; CT-fib ϭ high-resolution computed tomography score for interstitial infiltrates (see text for details); DL CO ϭ diffusing capacity for carbon monoxide; HRCT ϭ high-resolution computed tomography; NSIP ϭ nonspecific interstitial pneumonia; TLC ϭ total lung capacity; UIP ϭ usual interstitial pneumonia.
* 
Change in Serial Measurements over Time
Histologic diagnosis was significantly or marginally associated with changes in pulmonary function and radiographic characteristics over time (Table 3 ). In general, more patients with UIP had a decline in Dl CO compared with patients with NSIP, who were more likely to show an improvement in Dl CO over 6 or 12 months of follow-up (6-month p ϭ 0.03; 12-month p ϭ 0.05). Similarly, there was a trend for more patients with UIP to have a decline in FVC or TLC compared with patients with NSIP (6-month p ϭ 0.08, 0.07, respectively). Over 6 months of follow-up, a higher percentage of patients with UIP had an increase in CT-alv compared with patients with NSIP, who were more likely to show a decrease in CT-alv (p ϭ 0.07). Observed associations between histologic diagnosis and CT-fib percent changes over time were not statistically significant.
Survival
The 
Definition of abbreviations:
CT-alv ϭ HRCT score for ground glass; CT-fib ϭ HRCT score for interstitial infiltrates (see text for details); DL CO ϭ diffusing capacity for carbon monoxide; HRCT ϭ high-resolution computed tomography; NA ϭ not available; NSIP ϭ nonspecific interstitial pneumonia; PFT ϭ pulmonary function test; TLC ϭ total lung capacity; UIP ϭ usual interstitial pneumonia.
* p Value represents a comparison of UIP and NSIP and was calculated using Fisher's exact test.
a less than 10% change. Changes in CT-fib or TLC were not significant predictors of long-term survival when adjusted for the corresponding baseline values. Multivariate models of PFT and HRCT changes over time, adjusting for baseline value, histologic diagnosis, onset of symptoms before biopsy, smoking history, and gender were examined. A 6-month decrease in FVC of over 10% and a UIP diagnosis were significant predictors for reduced survival compared with patients with NSIP or moderate increases or decreases in FVC over time (Table 5 , Figure 1 ). The magnitude and direction of the hazard for the levels of FVC percent change are similar to the unadjusted model. No significant interaction between histologic diagnosis and demographic, physiologic, or radiographic variables was noted. Changes in TLC, Dl CO , CT-alv, and CT-fib did not contribute further information once these factors were included in the multivariate model. Baseline A-a gradient was not a significant predictor of survival in univariate (hazard ratio 1.0; 95% CI 0.98, 1.03; p ϭ 0.79) or multivariate analysis (hazard ratio 1.0; 95% CI 0.97, 1.04; p ϭ 0.65). Similar results were seen in a multivariable 12-month model, although change in FVC was no longer statistically significant.
DISCUSSION
Previous studies have identified the histopathologic pattern as the most important baseline factor in determining prognosis (1) (2) (3) (4) (5) . However, the disease course for individual patients with either UIP or NSIP can vary greatly. We hypothesized that shortterm changes in physiologic and radiographic criteria would give additional prognostic information to the baseline features of patients with UIP and NSIP.
In this report of a well-characterized group of patients with UIP or NSIP, we identify (1 ) that a decrease in FVC during the initial 6 months of follow-up is the best physiologic predictor of mortality, (2 ) a decrease in FVC during the initial 6 months after surgical lung biopsy gives additional information to other previously described predictive factors such as gender, smoking history, and histologic subtype (UIP or NSIP), and (3 ) patients with UIP are more likely to experience a decline in FVC or an increase in ground glass on HRCT over the first 6 months after surgical lung biopsy compared with patients with NSIP. These data aid in defining the optimal format of follow-up for patients with UIP or NSIP and identify the change in FVC over the first 6 months of follow-up as an important additional prognostic factor.
Our data demonstrate that change in FVC during follow-up is the strongest physiologic predictor of survival for patients with UIP and NSIP. The proportion of patients with a greater than 10% decrease in FVC during follow-up was greater in patients with UIP compared with patients with NSIP. Previous investigators have suggested that decreased FVC at baseline may identify patients at subsequent risk of mortality (18) (19) (20) (21) (22) (23) . In addition, some have suggested that a decrease in FVC of 10% or more after 1 year can predict mortality in patients with idiopathic pulmonary fibrosis (11) . Spirometric assessment is particularly valuable as its measurement is standardized (24) and the variability in FVC has been well defined among normal subjects and patients with pulmonary disease (24) . Despite these standards, previous investigators have noted variability in the physiology of patients with idiopathic interstitial pneumonia over time (25, 26) . As a result, a wide variety of thresholds for change in FVC have been used by investigators, including changes ranging from 10 to 15% in FVC (11, 22, (27) (28) (29) (30) . Our analyses document that a 10% decrease in FVC over a 6-month period from the time of the surgical lung biopsy exhibited strong predictive ability in defining long-term survival. Additional data have suggested that an increased profusion of fibroblastic foci is associated with a greater rate of decline in pulmonary function (10) and poorer survival (10, 31) . Our data expand these findings by demonstrating that change in FVC over a short duration of follow-up (6 months) is predictive of long-term survival and that this shortterm change in FVC gives additional prognostic information to the histopathologic classification. Our data are strengthened by Definition of abbreviations: CI, confidence interval; CT-alv ϭ high-resolution computed tomography score for ground glass; CT-fib ϭ high-resolution computed tomography score for interstitial infiltrates (see text for details); DL CO ϭ diffusing capacity for carbon monoxide; LR ϭ likelihood ratio; REF ϭ reference group; TLC ϭ total lung capacity. * p Value is from the likelihood ratio test of the addition of the levels of percent change to the model that included only the baseline measurements.
the inclusion of a well-characterized cohort with recent confirmation of the histopathologic pattern. The ability to look at a short-term change in FVC gives clinicians an additional tool to help determine prognosis for their patients and may be useful when making therapeutic decisions such as changing therapy or listing patients for lung transplantation. These data also suggest that a short-term change in FVC could be used as a surrogate marker for long-term mortality in therapeutic trials studying patients with UIP and NSIP. Twelve-month data were less predictive of survival; however, this is likely a consequence of a smaller number of patients available with 12-month serial data.
Our data suggest that the change in Dl CO over 6 months of follow-up has limited prognostic value. In multivariate analyses, short-term changes in Dl CO were not found to add independent predictive value. Although standards have been presented for its measurement (32) , the Dl CO varies to a greater extent than FVC and clinically significant changes have been believed to be more than 20% (11, 27, 28, 33) . As such, a survival advantage was noted by one group in patients with an improved or unchanged Dl CO compared with those experiencing a decrease of 20% or more after 1 year of therapy; the concordance between changes in FVC and Dl CO was quite good (11) . Importantly, our analysis suggests that changes in FVC better predict subsequent survival for patients with UIP and NSIP.
An increase in the semiquantitative HRCT score of CT-alv during the 6 months after biopsy was associated with an increased risk of mortality for patients with UIP in a model adjusting for the baseline CT-alv value. Short-term change in the semiquantitative HRCT score of CT-alv or CT-fib was not an independent predictor of survival when histologic diagnosis, sex, onset of symptoms, and smoking history were included in the models. Our data suggest that only minor changes occur in HRCT over the first 6 months of follow-up and may indicate that a semiquantitative HRCT scoring system lacks sensitivity to detect clinically useful, short-term changes in CT-alv or CTfib. Previous investigators have suggested that honeycombing on HRCT worsens over intermediate-term follow-up (12, (34) (35) (36) (37) , whereas improvement has been suggested in limited studies of patients with NSIP (38) (39) (40) . Use of computerized methods to quantify the amount of fibrosis and ground glass infiltrate (41, 42) may be more sensitive to serial changes in HRCT findings but require additional study. Additional studies are required to better define the role of serial HRCT in the follow-up and treatment for patients with UIP and NSIP.
In summary, we demonstrate that short-term changes in FVC are strongly predictive of long-term survival in patients with well-defined UIP and NSIP. Furthermore, short-term changes in FVC give additional prognostic information to previously described factors such as smoking history, gender, and histopathologic diagnosis. In contrast, serial changes in Dl CO and HRCT are of more limited value. 
